Login / Signup

Comparative effectiveness of sotrovimab and molnupiravir for prevention of severe covid-19 outcomes in patients in the community: observational cohort study with the OpenSAFELY platform.

Bang ZhengAmelia C A GreenJohn TazareHelen J CurtisLouis FisherLinda NabAnna SchultzeViyaasan MahalingasivamEdward P K ParkerWilliam J HulmeSebastian C J BaconNicholas J DeVitoChristopher BatesDavid EvansPeter InglesbyHenry DrysdaleSimon DavyJonathan CockburnCaroline E MortonGeorge HickmanTom WardRebecca M SmithJohn ParryFrank HesterSam HarperAmir MehrkarRosalind M EggoAlex J WalkerStephen J W EvansIan J DouglasBrian MacKennaBen GoldacreLaurie A Tomlinson
Published in: BMJ (Clinical research ed.) (2022)
In routine care of adult patients in England with covid-19 in the community, at high risk of severe outcomes from covid-19, those who received sotrovimab were at lower risk of severe outcomes of covid-19 than those treated with molnupiravir.
Keyphrases